South Korea
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 52.49 B |
Feb. 3, 2025 | USD 745.69 | 1.15% |
|
South Korea |
|
2 |
USD 26.69 B |
Feb. 3, 2025 | USD 119.86 | -2.20% |
|
South Korea |
|
3 |
USD 14.51 B |
Feb. 3, 2025 | USD 240.05 | -5.25% |
|
South Korea |
|
4 |
USD 6.79 B |
Feb. 3, 2025 | USD 83.97 | -5.00% |
|
South Korea |
|
5 |
USD 6.05 B |
Feb. 3, 2025 | USD 70.28 | -5.55% |
|
South Korea |
|
6 |
USD 2.64 B |
Feb. 3, 2025 | USD 32.21 | -3.61% |
|
South Korea |
|
7 |
USD 2.15 B |
Feb. 3, 2025 | USD 159.35 | -4.24% |
|
South Korea |
|
8 |
USD 1.62 B |
Feb. 3, 2025 | USD 34.59 | -4.65% |
|
South Korea |
|
9 |
USD 1.60 B |
Feb. 3, 2025 | USD 64.97 | -2.50% |
|
South Korea |
|
10 |
USD 1.34 B |
Feb. 3, 2025 | USD 18.22 | -3.57% |
|
South Korea |
|
11 |
USD 1.25 B |
Feb. 3, 2025 | USD 25.27 | 1.91% |
|
South Korea |
|
12 |
USD 1.24 B |
Feb. 3, 2025 | USD 54.68 | -7.62% |
|
South Korea |
|
13 |
USD 1.12 B |
Feb. 3, 2025 | USD 89.76 | -4.42% |
|
South Korea |
|
14 |
USD 1.08 B |
Feb. 3, 2025 | USD 88.80 | -5.65% |
|
South Korea |
|
15 |
USD 965.66 M |
Feb. 3, 2025 | USD 8.02 | 4.65% |
|
South Korea |
|
16 |
USD 878.90 M |
Feb. 3, 2025 | USD 7.21 | -0.62% |
|
South Korea |
|
17 |
USD 775.25 M |
Feb. 3, 2025 | USD 15.77 | -2.26% |
|
South Korea |
|
18 |
USD 774.24 M |
Feb. 3, 2025 | USD 56.39 | -4.53% |
|
South Korea |
|
19 |
USD 721.87 M |
Feb. 3, 2025 | USD 17.88 | -1.83% |
|
South Korea |
|
20 |
USD 589.04 M |
Feb. 3, 2025 | USD 6.82 | -1.91% |
|
South Korea |
|
21 |
USD 585.06 M |
Feb. 3, 2025 | USD 13.69 | -2.57% |
|
South Korea |
|
22 |
USD 550.59 M |
Feb. 3, 2025 | USD 77.77 | -3.69% |
|
South Korea |
|
23 |
USD 473.38 M |
Feb. 3, 2025 | USD 9.85 | -4.50% |
|
South Korea |
|
24 |
USD 457.91 M |
Feb. 3, 2025 | USD 9.61 | -3.70% |
|
South Korea |
|
25 |
USD 405.67 M |
Feb. 3, 2025 | USD 65.38 | -0.04% |
|
South Korea |
|
26 |
USD 402.16 M |
Feb. 3, 2025 | USD 8.66 | -7.96% |
|
South Korea |
|
27 |
USD 379.18 M |
Feb. 3, 2025 | USD 15.49 | -2.92% |
|
South Korea |
|
28 |
USD 364.77 M |
Feb. 3, 2025 | USD 15.36 | -2.10% |
|
South Korea |
|
29 |
USD 351.85 M |
Feb. 3, 2025 | USD 5.00 | -8.15% |
|
South Korea |
|
30 |
USD 351.07 M |
Feb. 3, 2025 | USD 6.88 | -1.99% |
|
South Korea |
|
31 |
USD 336.52 M |
Feb. 3, 2025 | USD 11.53 | -7.22% |
|
South Korea |
|
32 |
USD 312.87 M |
Feb. 3, 2025 | USD 33.57 | -2.13% |
|
South Korea |
|
33 |
USD 302.63 M |
Feb. 3, 2025 | USD 23.36 | -2.28% |
|
South Korea |
|
34 |
USD 300.30 M |
Feb. 3, 2025 | USD 8.83 | 4.03% |
|
South Korea |
|
35 |
USD 259.10 M |
Feb. 3, 2025 | USD 1.37 | -0.64% |
|
South Korea |
|
36 |
USD 249.52 M |
Feb. 3, 2025 | USD 11.00 | -3.03% |
|
South Korea |
|
37 |
USD 247.76 M |
Feb. 3, 2025 | USD 1.65 | -4.10% |
|
South Korea |
|
38 |
USD 224.89 M |
Feb. 3, 2025 | USD 3.10 | -3.13% |
|
South Korea |
|
39 |
USD 215.92 M |
Feb. 3, 2025 | USD 9.80 | -1.72% |
|
South Korea |
|
40 |
USD 210.90 M |
Feb. 3, 2025 | USD 16.51 | 0.47% |
|
South Korea |
|
41 |
USD 204.30 M |
Feb. 3, 2025 | USD 10.77 | -3.15% |
|
South Korea |
|
42 |
USD 197.78 M |
Feb. 3, 2025 | USD 12.66 | -2.66% |
|
South Korea |
|
43 |
USD 196.73 M |
Feb. 3, 2025 | USD 8.58 | -5.12% |
|
South Korea |
|
44 |
USD 178.28 M |
Feb. 3, 2025 | USD 1.18 | -3.42% |
|
South Korea |
|
45 |
USD 167.34 M |
Feb. 3, 2025 | USD 5.23 | -2.06% |
|
South Korea |
|
46 |
USD 166.53 M |
Feb. 3, 2025 | USD 11.86 | -0.20% |
|
South Korea |
|
47 |
USD 165.16 M |
Feb. 3, 2025 | USD 8.44 | -2.89% |
|
South Korea |
|
48 |
USD 162.01 M |
Feb. 3, 2025 | USD 4.14 | -7.03% |
|
South Korea |
|
49 |
USD 155.82 M |
Feb. 3, 2025 | USD 11.83 | -21.52% |
|
South Korea |
|
50 |
USD 148.47 M |
Feb. 3, 2025 | USD 31.05 | -1.12% |
|
South Korea |
The Healthcare company in South Korea with the highest Market Capitalization is Samsung Biologics Co.,Ltd. (KSE: 207940.KS) at USD 52.49 B.
The Healthcare company in South Korea with the lowest Market Capitalization is PCL, Inc. (KOSDAQ: 241820.KQ) at USD 17.21 M.
The top 10 Healthcare companies in South Korea by Market Capitalization are Samsung Biologics Co.,Ltd., Celltrion, Inc., ALTEOGEN Inc., Yuhan Corporation, SK Biopharmaceuticals Co., Ltd., SK bioscience Co.,Ltd., Hanmi Pharm. Co., Ltd., Celltrion Pharm, Inc., Peptron, Inc. and Hanmi Science Co., Ltd..
The bottom 10 Healthcare companies in South Korea by Market Capitalization are PCL, Inc., Gencurix Inc., BCWORLD PHARM. Co., Ltd., Wooridul Huebrain Limited, MYUNGMOON Pharm co.,Ltd, Yuyu Pharma, Inc., PharmGen Science, Inc., EOFLOW Co.,Ltd., Sugentech Inc. and Kukje Pharma Co., Ltd..